The U.S Central Command continues to back the use of Seroquel, a powerful antipsychotic, to treat insomnia in troops deployed to combat zones despite an expert panel's recommendation six months ago to ...
The most common (Greater Than or Equal To 5% of patients) treatment emergent adverse events for the SEROQUEL XR group versus placebo group in the randomized phase were insomnia (8.5% vs 17.5%) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback